Read about MED

London stock exchange

The MED board (the “Board”) aims to conform to its statutory responsibilities and industry good practice in relation to corporate governance of MED (“MED” or the “Company”) and its (future) subsidiaries. The Board has adopted the latest version of the QCA Corporate Governance Code (2018) (“QCA Code”) and endeavours to follow its ten principles (“the Principles”) with due regard to the stage of development of the Company. The Company also seeks guidance from its Advisors on recommended best corporate governance practice for LSE companies.

In addition to my role as Non – executive chairman of the Board, I am also the chairman of the Company’s Governance Committee and retain primary responsibility for the design, implementation, articulation, review and updates of the Company’s corporate governance policy. The Governance Committee meets at least once a year and makes recommendations to the Board to ensure the Company’s corporate governance policy remains aligned with the Principles as it grows.

Download Our Corporate Presentation

There are no restrictions on the transfer of securities.

Auditors

Crowe U.K. LLP
55 Ludgate Hill
London
EC4M 7JW

Broker

Clear Capital Markets
Broadgate Tower
12th Floor
Office 1213
20 Primrose Street
London
EC2A 2EW

Legal

Druces LLP
Salisbury House
London Wall
London, EC2M 5PS

PR/IR

No Advisor Appointed as yet

Company Secretary

Noel O’Keeffe
Salisbury House
London Wall
London, EC2M 5PS

Registrar

Link Group
Unit 10
Central Square
29 Wellington Street
Leeds
LS1 4DL

Not available at this time

Not available at this time

Get In Touch

If you are interested in working with us then please drop us a line, we would love to hear from you.

contact us